
Cybin Launches US$100 Million At-the-Market Equity Program

I'm PortAI, I can summarize articles.
Cybin Inc. has launched a US$100 million at-the-market equity program to issue and sell common shares through Cantor Fitzgerald & Co. The program, valid until October 17, 2027, allows flexible access to funding for growth and working capital. Analysts currently rate Cybin's stock as a Hold with a price target of C$0.13, citing weak financial performance but noting positive developments in clinical milestones and corporate visibility. Cybin operates as a foreign private issuer, listing shares on Cboe Canada and U.S. exchanges.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

